SCHEDULE 13G/A: AllianceBernstein L.P. Updates 2.2% Stake in Pediatrix Medical Group Inc.
Beneficial Ownership Disclosure
AllianceBernstein L.P. has filed an Amendment No. 6 to Schedule 13G, disclosing a 2.2% beneficial ownership stake in Pediatrix Medical Group Inc. as of May 31, 2025.
Summary
- AllianceBernstein L.P. reported beneficial ownership of 1,928,272 shares of Pediatrix Medical Group Inc. common stock.
- This ownership represents 2.2% of the class of securities.
- AllianceBernstein L.P. holds sole voting power over 1,769,147 shares and sole dispositive power over 1,928,272 shares.
- The shares were acquired solely for investment purposes on behalf of client discretionary investment advisory accounts.
- The filing is an Amendment No. 6 to a previous Schedule 13G, indicating an update to their previously reported holdings.
Sentiment
Score: 6
Explanation: The filing is a standard regulatory disclosure of an institutional investment stake. While not explicitly positive or negative, the continued holding by a major investment firm for investment purposes can be interpreted as a neutral to slightly positive signal regarding their view of the company.
Positives
- The continued beneficial ownership by a major institutional investor like AllianceBernstein L.P. for investment purposes can be viewed as a sign of confidence in Pediatrix Medical Group Inc.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding Pediatrix Medical Group Inc.'s future performance or operations.
Industry Context
This filing represents a routine disclosure by a significant institutional investment manager, AllianceBernstein L.P., regarding its passive investment stake in Pediatrix Medical Group Inc., a company operating in the healthcare services sector. Such filings are common and reflect ongoing portfolio management activities by large asset managers.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 05/31/2025 | Date of event which requires filing of this statement (measurement date for ownership). |
| 06/03/2025 | Date of signature and filing of the Schedule 13G Amendment No. 6. |
Keywords
Pediatrix Medical Group Inc., AllianceBernstein L.P., SEC filing, Schedule 13G, beneficial ownership, common stock, investment adviser, healthcare services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.